HUNTINGTON NATIONAL BANK - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16
-15.8%
20.0%0.00%
Q2 2023$19
-99.7%
2
-99.7%
0.00%
Q1 2023$6,938
+42.0%
633
-44.0%
0.00%
Q4 2022$4,886
-18.6%
1,131
+53.7%
0.00%
Q3 2022$6,000
-14.3%
7360.0%0.00%
Q2 2022$7,000
-36.4%
736
-18.8%
0.00%
Q1 2022$11,000
-38.9%
906
+15.6%
0.00%
Q4 2021$18,000
+5.9%
784
+0.1%
0.00%
Q3 2021$17,000
-10.5%
783
-46.3%
0.00%
Q2 2021$19,000
-5.0%
1,457
-5.0%
0.00%
Q1 2021$20,0001,5340.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders